Ms. Graham currently serves as Aadi’s Senior Vice President of Investor Relations and Corporate Communications, joining the Company in May 2022. She brings more than 20 years of experience to the role, having led these functional areas primarily at biotech and pharmaceutical companies in all stages of development. Ms. Graham most recently served as the Vice President of Corporate Affairs at Poseida Therapeutics, taking the company public in 2020 after joining in 2018. Prior to that role, Ms. Graham was Vice President IR and Corporate Communications at Mirati Therapeutics and had previously led investor relations and corporate communications for Ambit Biosciences prior to its eventual acquisition by Daiichi Sankyo in 2014. Other roles include similar functions with diagnostics companies Sequenom and Genoptix, the latter of which was acquired by Novartis in 2011. Ms. Graham earned an MBA from the University of New Mexico, Anderson School of Management and a BA in journalism, most recently completing the Strategic Financial Leadership Program at Stanford Graduate School of Business.